摘要
目的研究Peutz-Jeghers综合征(Peutz-Jeghers syndrome,PJS)胃肠道息肉的药物干预性治疗进展。方法对有关PJS胃肠道息肉的药物干预性治疗的文献进行综述分析,对新近取得突破性进展的靶向治疗药物(选择性环氧合酶-2抑制剂和雷帕霉素)的相关资料进行重点总结。结果随着国内、外对PJS基础研究的深入及新型药物的研制应用,PJS胃肠道息肉的治疗出现了药物干预性治疗的新进展;人工合成的环氧合酶-2抑制剂和雷帕霉素在临床上的应用为PJS胃肠道息肉的治疗开辟了一条新的途径。结论选择性环氧合酶-2抑制剂和雷帕霉素具有无创、选择性强及疗效好的特点,使PJS胃肠道息肉的治疗进入靶向治疗阶段,它们在临床上应用于PJS胃肠道息肉的治疗具有广阔的应用前景。
Objective To investigate the medication advancement of gastrointestinal polyposis in patients with Peutz-Jeghers syndrome （PJS）. Methods Literatures about the medication advancement on gastrointestinal polyposis of PJS were reviewed and analyzed. The recent development of targeting drugs, especially the data of cyclooxygenase-2 selective inhibitors and rapamycin, were emphatically summarized. Results With the deep investigation of PJS and application of selective drugs, the medication of gastrointestinal polyposis in cases of PJS has got more advancement. The extensive use of synthetic cyclooxygenase-2 inhibitors and rapamycin in clinic developed a new way to treat gastrointestinal polyposis of PJS. Conclusion The cyclooxygenase-2 selective inhibitors and rapamycin have the following features： noninvasive, high selectivity and good curative effects. They have splendid prospects in the clinical treatment of gastrointestinal polyposis in patients with PJS and are bring the treatment of gastrointestinal polyposis in cases of PJS into a targeting therapy phase.
出处
《中国普外基础与临床杂志》
CAS
2009年第4期333-335,共3页
Chinese Journal of Bases and Clinics In General Surgery
